Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery

Archives of Surgery

Volumn 142, Issue 6, 2007, Pages 554-559

  Oh, Daniel S ^a   DeMeester, Steven R ^b   Vallbohmer, Daniel ^a   Mori, Ryutaro ^b   Kuramochi, Hidekazu ^b   Hagen, Jeffrey A ^a   Lipham, John ^a   Danenberg, Kathleen D ^b,c   Danenberg, Peter V ^b   Chandrasoma, Parakrama ^b   DeMeester, Tom R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Response Genetics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; MESSENGER RNA; PARAFFIN;

ANTIREFLUX OPERATION; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; GASTROINTESTINAL ENDOSCOPY; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MICRODISSECTION; PATIENT CODING; PH MEASUREMENT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REFLUX ESOPHAGITIS; REVERSE TRANSCRIPTION; RNA ISOLATION; STOMACH FUNDOPLICATION; STROMA;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGITIS, PEPTIC; FUNDOPLICATION; GASTROESOPHAGEAL REFLUX; HUMANS; INTERLEUKIN-8; RNA, MESSENGER;

EID: 34250751794     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.142.6.554     Document Type: Article

References (19)

1. Tobey NA, Hosseini SS, Argote CM, et al. Dilated intercellular spaces and shunt permeability in nonerosive acid-damaged esophageal epithelium. Am J Gastroenterol. 2004;99:13-22.
2. Demeester SR, Peters JH, Demeester TR. Barrett's esophagus. Curr Probl Surg. 2001;38:558-640.
3. Balkwill F, Coussens LM. Cancer: an inflammatory link. Nature. 2004;431:405-406.
4. Konturek PC, Nikiforuk A, Kania J, et al. Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors. Dig Dis Sci. 2004;49:1075-1083.
5. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066-1071.
6. Abdel-Latif MMM, O'Riordan J, Windle HJ, et al. NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg. 2004;239:491-500.
7. O'Riordan JM, Abdel-latif MM, Ravi N, et al. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia- adenocarcinoma sequence in the esophagus. Am J Gastroenterol. 2005;100:1257-1264.
8. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 2001; 12:375-391.
9. Tanaka K, Oh DS, DeMeester SR, et al. Gene expression of IL-8 and IL-1Beta: quantitative biomarkers of esophageal squamous injury [abstract]. Gastroenterology. 2006;130(suppl 2):M2013.
10. DeMeester TR, Bonavina L, Albertucci M. Nissen fundoplication for gastroesophageal reflux disease: evaluation of primary repair in 100 consecutive patients. Ann Surg. 1986;204:9-20.
11. Peters JH, DeMeester TR, Crookes P, et al. The treatment of gastroesophageal reflux disease with laparoscopic Nissen fundoplication: prospective evaluation of 100 patients with "typical" symptoms. Ann Surg. 1998;228:40-50.
12. Oh DS, Demeester SR, Hagen JA, et al. Cox-2 gene expression in long segment Barrett's esophagus is inflammatory in origin [abstract]. Gastroenterology. 2006; 130(suppl 2):M1881.
13. Fitzgerald RC, Abdalla S, Onwuegbusi BA, et al. Inflammatory gradient in Barrett's oesophagus: implications for disease complications. Gut. 2002;51:316-322.
14. Vallböhmer D, DeMeester SR, Oh DS, et al. Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus. Am J Gastroenterol. 2006;101:1458-1466.
15. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005; 97:142-146.
16. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999; 340:825-831.
17. Oh DS, Hagen JA, Fein M, et al. Impact of reflux composition on mucosal injury and esophageal function. J Gastrointest Surg. 2006;10:787-797.
18. DeMeester TR. Surgical therapy for Barrett's esophagus: prevention, protection and excision. Dis Esophagus. 2002;15:109-116.
19. Isomoto H, Saenko VA, Kanazawa Y, et al. Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease. Am J Gastroenterol. 2004;99:589-597.